Corticosteroids Therapy and Pneumocystis Jirovecii Pneumonia (PCP)

Withdrawn before enrolling · Phase 4

Conditions studied: Pneumocystis Carinii Pneumonia

In brief

To explore the effects of corticosteroid therapy on pulmonary fibrosis and potentially pneumothorax in patients with mild PCP (pO2 \>70mmHg) combined with the standard of care treatment of antibiotic therapy.

Key facts

Study ID

NCT00636935

Run by

George Washington University

People needed

0

Starts

2008-02-01

Expected to finish

2013-08-01

Last updated by the study team

2017-06-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• HIV Infection,
• Hospital admission for suspected PCP,
• Confirmatory test for PCP (bronchoscopy with bronchoalveolar lavage), pO2>70 mmHg or pO2<70 mmHg while breathing room air,
• 18 years or older

You may not qualify if…

• Contraindications to corticosteroid therapy,
• Unable and or unwilling to perform PFTS or to return for follow-up evaluations,
• Underlying lung disease such as emphysema, untreated active tuberculosis, Uncontrolled diabetes (fasting glucose > 250 mg/dL,
• Uncontrolled hypertension (160/95 mmHg),
• Pregnancy

Where it is running

• George Washington University Medical Faculty Associates — Washington D.C., District of Columbia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.